Colson C, Wang Y, Atherton J, Su X
bioRxiv. 2024; .
PMID: 39091866
PMC: 11291067.
DOI: 10.1101/2024.07.23.604788.
Ayoup M, Barakat M, Abdel-Hamid H, Emam E, Al-Faiyz Y, Masoud A
RSC Med Chem. 2024; 15(6):2080-2097.
PMID: 38911158
PMC: 11187554.
DOI: 10.1039/d4md00113c.
Naoi M, Maruyama W, Shamoto-Nagai M, Riederer P
J Neural Transm (Vienna). 2024; 131(6):639-661.
PMID: 38196001
DOI: 10.1007/s00702-023-02730-6.
Riederer P, Horowski R
J Neural Transm (Vienna). 2023; 130(11):1323-1335.
PMID: 37796288
PMC: 10645634.
DOI: 10.1007/s00702-023-02692-9.
Mishra P, Kumar A, Kaur K, Jaitak V
Curr Med Chem. 2023; 31(35):5702-5738.
PMID: 37455459
DOI: 10.2174/0929867331666230714160047.
Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders.
Ahsan M, Ali A, Ali A, Thiriveedhi A, Bakht M, Yusuf M
ACS Omega. 2022; 7(43):38207-38245.
PMID: 36340076
PMC: 9631758.
DOI: 10.1021/acsomega.2c05339.
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.
Arshad J, Hanif M
RSC Med Chem. 2022; 13(10):1127-1149.
PMID: 36325396
PMC: 9579940.
DOI: 10.1039/d2md00175f.
Antidepressant-like effect of a seeds in mice: Involvement of the monoaminergic system.
Sabrina Anzollin G, Zaki L, Perin T, Finger B, Perin L, Petry F
J Tradit Complement Med. 2022; 12(4):309-317.
PMID: 35747347
PMC: 9209823.
DOI: 10.1016/j.jtcme.2021.08.013.
Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.
Aljanabi R, Alsous L, Sabbah D, Gul H, Gul M, Bardaweel S
Molecules. 2021; 26(19).
PMID: 34641563
PMC: 8513016.
DOI: 10.3390/molecules26196019.
The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.
Goldstein D
Int J Mol Sci. 2021; 22(11).
PMID: 34206133
PMC: 8199574.
DOI: 10.3390/ijms22115999.
Chromenone Derivatives as Monoamine Oxidase Inhibitors from Marine-Derived MAR4 Clade sp. CNQ-031.
Oh J, Lee C, Nam S, Kim H
J Microbiol Biotechnol. 2021; 31(7):1022-1027.
PMID: 34099598
PMC: 9706024.
DOI: 10.4014/jmb.2105.05003.
Protein profiling identified mitochondrial dysfunction and synaptic abnormalities after dexamethasone intervention in rats with traumatic brain injury.
Niu F, Zhang B, Feng J, Mao X, Xu X, Dong J
Neural Regen Res. 2021; 16(12):2438-2445.
PMID: 33907032
PMC: 8374556.
DOI: 10.4103/1673-5374.313047.
SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
Unzeta M, Hernandez-Guillamon M, Sun P, Sole M
Int J Mol Sci. 2021; 22(7).
PMID: 33805974
PMC: 8036996.
DOI: 10.3390/ijms22073365.
Monoamine oxidase A activity in fibroblasts as a functional confirmation of variants.
Peters T, Lammerts van Bueren I, Geurtz B, Coene K, de Leeuw N, Brunner H
JIMD Rep. 2021; 58(1):114-121.
PMID: 33728254
PMC: 7932864.
DOI: 10.1002/jmd2.12194.
WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors.
Scarpino A, Petri L, Knez D, Imre T, Abranyi-Balogh P, Ferenczy G
J Comput Aided Mol Des. 2021; 35(2):223-244.
PMID: 33458809
PMC: 7904743.
DOI: 10.1007/s10822-020-00371-5.
Design, synthesis, molecular modelling and screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives.
Amer A, Hegazi A, Alshekh M, Ahmed H, Soliman S, Maniquet A
R Soc Open Sci. 2020; 7(4):200050.
PMID: 32431898
PMC: 7211837.
DOI: 10.1098/rsos.200050.
Amphetamine Derivatives as Monoamine Oxidase Inhibitors.
Reyes-Parada M, Iturriaga-Vasquez P, Cassels B
Front Pharmacol. 2020; 10:1590.
PMID: 32038257
PMC: 6989591.
DOI: 10.3389/fphar.2019.01590.
The discovery and development of rasagiline as a new anti-Parkinson medication.
Finberg J
J Neural Transm (Vienna). 2020; 127(2):125-130.
PMID: 31974721
DOI: 10.1007/s00702-020-02142-w.
The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.
Pitsillou E, Bresnehan S, Kagarakis E, Wijoyo S, Liang J, Hung A
Mol Biol Rep. 2019; 47(1):753-770.
PMID: 31612411
DOI: 10.1007/s11033-019-05129-3.
Selegiline: a molecule with innovative potential.
Tabi T, Vecsei L, Youdim M, Riederer P, Szoko E
J Neural Transm (Vienna). 2019; 127(5):831-842.
PMID: 31562557
PMC: 7242272.
DOI: 10.1007/s00702-019-02082-0.
